Recently, combined RRM2 and CHK1 inhibition was shown to be synergistic in neuroblastoma xenografts owing to replicative stress due to stalled replication forks61, a process in which TOP2, the target of etoposide, also plays a role62. The gene discussed is RRM2; the disease is neuroblastoma.